Biallelic <i>RP1</i>-associated retinal dystrophies: Expanding the mutational and clinical spectrum.
Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Mark E. Pennesi(University of Pennsylvania), Lucy H. Young, Eric A. Pierce(Broad Institute), Paul Yang(Oregon Health & Science University), Demetrios G. Vavvas(Massachusetts Eye and Ear Infirmary), Florin Grigorian(University of Arkansas at Little Rock), Jason Comander(Massachusetts Eye and Ear Infirmary), Emily Place(MACOM (United States)), М. Ф. Шурыгина(Oregon Health & Science University)
PubMed
January 1, 2020
Cited by 9
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k